BioMarin Pharmaceuticals
BMRN
BMRN
526 hedge funds and large institutions have $22.3B invested in BioMarin Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 88 funds opening new positions, 204 increasing their positions, 166 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
5% more funds holding
Funds holding: 499 → 526 (+27)
1.82% more ownership
Funds ownership: 98.47% → 100.29% (+1.8%)
0% more funds holding in top 10
Funds holding in top 10: 11 → 11 (0)
Holders
526
Holding in Top 10
11
Calls
$222M
Puts
$182M
Top Buyers
| 1 | +$169M | |
| 2 | +$157M | |
| 3 | +$150M | |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$114M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$84.8M |
Top Sellers
| 1 | -$200M | |
| 2 | -$123M | |
| 3 | -$76.9M | |
| 4 |
ClearBridge Investments
New York
|
-$49.8M |
| 5 |
State Street
Boston,
Massachusetts
|
-$48.5M |